PlainRecalls
FDA Drug Moderate Class II Ongoing

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Reported: August 7, 2024 Initiated: July 26, 2024 #D-0624-2024

Product Description

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Reason for Recall

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

Details

Recalling Firm
Eugia US LLC
Units Affected
17136 vials
Distribution
Nationwide in the USA
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.. Recalled by Eugia US LLC. Units affected: 17136 vials.
Why was this product recalled?
Presence of Particulate Matter: Complaint received of a glass particle in the vial.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 7, 2024. Severity: Moderate. Recall number: D-0624-2024.